Trials / Withdrawn
WithdrawnNCT01983943
Olive Oil and Cardiovascular Health
Effects of Hydroxytyrosol on Vascular Health
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Mayo Clinic · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to conduct a double-blind, randomized controlled trial (RCT), to determine if six month supplementation of olive oil can improve the health of the blood vessels and improve long term health of the heart and blood vessels, in patients requiring percutaneous coronary intervention (PCI).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Hydroxytyrosol, the active ingredient in olive oil. | A 40mg capsule will be taken once daily for 6 months. |
| DIETARY_SUPPLEMENT | Placebo | A 40mg placebo will be taken once per day for 6 months. |
| BEHAVIORAL | Nutrition counseling | Nutrition counseling on eating a healthy diet will be offered once at baseline. |
| DEVICE | Endopat | An endopat test will be administered twice, once and baseline and once after 6 months of supplementation, to test endothelial function. This is a non-invasive test that takes about 15 minutes. |
Timeline
- Start date
- 2013-08-01
- Primary completion
- 2014-07-01
- Completion
- 2014-07-01
- First posted
- 2013-11-14
- Last updated
- 2015-06-03
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01983943. Inclusion in this directory is not an endorsement.